Alex Ekubo Dies After Kidney Cancer Battle, Hospitalized Monday

Renowned Nollywood actor Alex Ekubo has died, after a brief hospitalization for a serious illness that was later identified as kidney cancer. The actor was rushed to a Lagos hospital on Monday, where he was placed on life support. Despite intensive medical care, Ekubo succumbed to his condition on Tuesday afternoon.

The news was confirmed by a senior source within the Nigerian film industry who asked to remain anonymous. The source said Ekubo had been battling kidney cancer for some months, a fact that had not been publicly disclosed. The actor’s death marks a significant loss for the Nigerian entertainment sector, which had celebrated his performances in films such as “Sincerely, Daisy” and “Third Party.”

Ekubo’s health had become a subject of speculation after he vanished from social media in May of last year. A routine check of his public profiles revealed his last post dated 30 December 2024, after which he fell silent for an extended period. The absence fueled rumors about his wellbeing, but no official statement was released until now.

Industry colleagues expressed shock and grief on social media platforms, recalling Ekubo’s contributions to Nollywood’s growth and his reputation as a dedicated professional. While fans and fellow actors mourn the loss, the film community is also reflecting on the broader issue of health awareness among entertainers, many of whom face demanding schedules and limited access to regular medical screening.

The family has not yet issued a public statement regarding funeral arrangements or memorial services. Media representatives have requested privacy for the bereaved relatives during this difficult time.

Ekubo’s death underscores the need for heightened attention to health challenges in the creative sector, where occupational pressures can exacerbate underlying conditions. As Nollywood continues to expand its global reach, stakeholders are being urged to prioritize wellness initiatives for actors and crew alike.

Further updates will be provided as more details become available.